PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling

Mitochondrion

Volumn 12, Issue 1, 2012, Pages 86-99

  Jones, Aleck W E ^a   Yao, Zhi ^a   Vicencio, Jose Miguel ^a   Karkucinska Wieckowska, Agnieszka ^b   Szabadkai, Gyorgy ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Apoptosis; Cancer; Cellular stress response; Mitochondrial biogenesis; Neurodegeneration; Pgc 1; Retrograde signalling

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA;

ADAPTATION; APOPTOSIS; BIOGENESIS; CARDIOVASCULAR DISEASE; CELL ENERGY; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; DEGENERATIVE DISEASE; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETIC CONSERVATION; HUMAN; MITOCHONDRION; NEOPLASM; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; NEOPLASMS; NEURODEGENERATIVE DISEASES; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 84856544687     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.09.009     Document Type: Review

References (213)

1. Acin-Perez R., Salazar E., Brosel S., Yang H., Schon E.A., Manfredi G. Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cytochrome oxidase defects. EMBO Mol. Med. 2009, 1:392-406.
2. Adhihetty P.J., Taivassalo T., Haller R.G., Walkinshaw D.R., Hood D.A. The effect of training on the expression of mitochondrial biogenesis- and apoptosis-related proteins in skeletal muscle of patients with mtDNA defects. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E672-E680.
3. Amuthan G., Biswas G., Zhang S.Y., Klein-Szanto A., Vijayasarathy C., Avadhani N.G. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J. 2001, 20:1910-1920.
4. Amuthan G., Biswas G., Ananadatheerthavarada H.K., Vijayasarathy C., Shephard H.M., Avadhani N.G. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 2002, 21:7839-7849.
5. Andersson U., Scarpulla R.C. Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol. Cell. Biol. 2001, 21:3738-3749.
6. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., Ahmad F., Matsui T., Chin S., Wu P.-H., Rybkin I.I., Shelton J.M., Manieri M., Cinti S., Schoen F.J., Bassel-Duby R., Rosenzweig A., Ingwall J.S., Spiegelman B.M. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005, 1:259-271.
7. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10086-10091.
8. Arany Z., Foo S.-Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G., Cooper M., Laznik D., Chinsomboon J., Rangwala S.M., Baek K.H., Rosenzweig A., Spiegelman B.M. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008, 451:1008-1012.
9. Arnould T., Vankoningsloo S., Renard P., Houbion A., Ninane N., Demazy C., Remacle J., Raes M. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J. 2002, 21:53-63.
10. Bai R.K., Leal S.M., Covarrubias D., Liu A., Wong L.J. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 2007, 67:4687-4694.
11. Baker B.M., Haynes C.M. Mitochondrial protein quality control during biogenesis and aging. Trends Biochem. Sci. 2011, 36:254-261.
12. Baker M.J., Tatsuta T., Langer T. Quality control of mitochondrial proteostasis. Cold Spring Harbor Perspectives in Biology 2011, 3.
13. Basu A., Lenka N., Mullick J., Avadhani N.G. Regulation of murine cytochrome oxidase Vb gene expression in different tissues and during myogenesis. Role of a YY-1 factor-binding negative enhancer. J. Biol. Chem. 1997, 272:5899-5908.
14. Bianchi K., Vandecasteele G., Carli C., Romagnoli A., Szabadkai G., Rizzuto R. Regulation of Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator PGC-1alpha. Cell Death Differ. 2006, 13:586-596.
15. Biswas G., Adebanjo O.A., Freedman B.D., Anandatheerthavarada H.K., Vijayasarathy C., Zaidi M., Kotlikoff M., Avadhani N.G. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J. 1999, 18:522-533.
16. Biswas G., Anandatheerthavarada H.K., Avadhani N.G. Mechanism of mitochondrial stress-induced resistance to apoptosis in mitochondrial DNA-depleted C2C12 myocytes. Cell Death Differ. 2005, 12:266-278.
17. Biswas G., Tang W., Sondheimer N., Guha M., Bansal S., Avadhani N.G. A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. J. Biol. Chem. 2008, 283:12586-12594.
18. Booker L.M., Habermacher G.M., Jessie B.C., Sun Q.C., Baumann A.K., Amin M., Lim S.D., Fernandez-Golarz C., Lyles R.H., Brown M.D., Marshall F.F., Petros J.A. North American white mitochondrial haplogroups in prostate and renal cancer. J. Urol. 2006, 175:468-472. discussion 472-463.
19. Borniquel S., Valle I., Cadenas S., Lamas S., Monsalve M. Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha. The FASEB journal: Official Publication of the Federation of American Societies for Experimental Biology 2006, 20:1889-1891.
20. Brandon M., Baldi P., Wallace D.C. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
21. Broadley S.A., Hartl F.U. Mitochondrial stress signaling: a pathway unfolds. Trends Cell Biol. 2008, 18:1-4.
22. Burchard J., Zhang C., Liu A.M., Poon R.T.P., Lee N.P.Y., Wong K.-F., Sham P.C., Lam B.Y., Ferguson M.D., Tokiwa G., Smith R., Leeson B., Beard R., Lamb J.R., Lim L., Mao M., Dai H., Luk J.M. MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 2010, 6.
23. Butow R.A., Avadhani N.G. Mitochondrial signaling: the retrograde response. Mol. Cell 2004, 14:1-15.
24. Butow R.A., Docherty R., Parikh V.S. A path from mitochondria to the yeast nucleus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1988, 319:127-133.
25. Calvo S.E., Mootha V.K. The mitochondrial proteome and human disease. Annu. Rev. Genomics Hum. Genet. 2010, 11:25-44.
26. Cam H., Balciunaite E., Blais A., Spektor A., Scarpulla R.C., Young R., Kluger Y., Dynlacht B.D. A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell 2004, 16:399-411.
27. Chandra D., Singh K.K. Genetic insights into OXPHOS defect and its role in cancer. Biochim. Biophys. Acta 2010, 1807(6):620-625.
28. Chandra D., Singh K.K. Genetic insights into OXPHOS defect and its role in cancer. Biochim. Biophys. Acta (BBA) - Bioenerg. 2011, 1807:620-625.
29. Chaturvedi R.K., Adhihetty P., Shukla S., Hennessy T., Calingasan N., Yang L., Starkov A., Kiaei M., Cannella M., Sassone J., Ciammola A., Squitieri F., Beal M.F. Impaired PGC-1alpha function in muscle in Huntington's disease. Hum. Mol. Genet. 2009, 18:3048-3065.
30. Chen E.J., Kaiser C.A. LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway. J. Cell Biol. 2003, 161:333-347.
31. Chen X.J., Wang X., Kaufman B.A., Butow R.A. Aconitase couples metabolic regulation to mitochondrial DNA maintenance. Science 2005, 307:714-717.
32. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The BCL-2 family reunion. Mol. Cell 2010, 37:299-310.
33. Clark J., Reddy S., Zheng K., Betensky R., Simon D. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. BMC Med. Genet. 2011, 12:69.
34. Connaughton S., Chowdhury F., Attia R.R., Song S., Zhang Y., Elam M.B., Cook G.A., Park E.A. Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol. Cell. Endocrinol. 2010, 315:159-167.
35. Cowell R.M., Talati P., Blake K.R., Meador-Woodruff J.H., Russell J.W. Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. Biochem. Biophys. Res. Commun. 2009, 379:578-582.
36. Crimi M., Bordoni A., Menozzi G., Riva L., Fortunato F., Galbiati S., Del Bo R., Pozzoli U., Bresolin N., Comi G.P. Skeletal muscle gene expression profiling in mitochondrial disorders. Faseb J. 2005, 19:866-868.
37. Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006, 127:59-69.
38. Czarnecka A.M., Kukwa W., Krawczyk T., Scinska A., Kukwa A., Cappello F. Mitochondrial DNA mutations in cancer-from bench to bedside. Front. Biosci. 2010, 15:437-460.
39. Czubryt M.P., McAnally J., Fishman G.I., Olson E.N. Regulation of peroxisome proliferator-activated receptor Πcoactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. 2003, 100:1711-1716.
40. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7:11-20.
41. Deblois G., Chahrour G., Perry M.-C., Sylvain-Drolet G., Muller W.J., Giguère V. Transcriptional control of the ERBB2 amplicon by ERR{alpha} and PGC-1{beta} promotes mammary gland tumorigenesis. Cancer Res. 2010, 70:10277-10287.
42. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
43. Duchen M.R., Szabadkai G. Roles of mitochondria in human disease. Essays Biochem. 2010, 47:115-137.
44. Duchen M.R., Verkhratsky A., Muallem S. Mitochondria and calcium in health and disease. Cell Calcium 2008, 44:1-5.
45. Epstein C.B., Waddle J.A., Hale W.I.V., Dave V., Thornton J., Macatee T.L., Garner H.R., Butow R.A. Genome-wide responses to mitochondrial dysfunction. Mol. Biol. Cell 2001, 12:297-308.
46. Esterbauer H., Oberkofler H., Krempler F., Patsch W. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 1999, 62:98-102.
47. Fadeel B., Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 2005, 258:479-517.
48. Feilchenfeldt J., Bründler M.A., Soravia C., Tötsch M., Meier C.A. Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1). Cancer Lett. 2004, 203:25-33.
49. Fish J., Raule N., Attardi G. Discovery of a major D-loop replication origin reveals two modes of human mtDNA synthesis. Science 2004, 306:2098-2101.
50. Fjeld C.C., Birdsong W.T., Goodman R.H. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9202-9207.
51. Galluzzi L., Maiuri M.C., Vitale I., Zischka H., Castedo M., Zitvogel L., Kroemer G. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007, 14:1237-1243.
52. Garnier A., Fortin D., Deloménie C., Momken I., Veksler V., Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 2003, 551:491-501.
53. Gasparre G., Romeo G., Rugolo M., Porcelli A.M. Learning from oncocytic tumors: why choose inefficient mitochondria?. Biochim. Biophys. Acta (BBA) - Bioenerg. 2011, 1807:633-642.
54. Gohil V.M., Greenberg M.L. Mitochondrial membrane biogenesis: phospholipids and proteins go hand in hand. J. Cell Biol. 2009, 184:469-472.
55. Gopalakrishnan L., Scarpulla R.C. Differential regulation of respiratory chain subunits by a CREB-dependent signal transduction pathway. Role of cyclic AMP in cytochrome c and COXIV gene expression. J. Biol. Chem. 1994, 269:105-113.
56. Guerra F., Kurelac I., Cormio A., Zuntini R., Amato L.B., Ceccarelli C., Santini D., Cormio G., Fracasso F., Selvaggi L., Resta L., Attimonelli M., Gadaleta M.N., Gasparre G. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Hum. Mol. Genet. 2011, 20:2394-2405.
57. Guha M., Srinivasan S., Biswas G., Avadhani N.G. Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress. J. Biol. Chem. 2007, 282:14536-14546.
58. Guha M., Pan H., Fang J.K., Avadhani N.G. Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress. Mol. Biol. Cell 2009, 20:4107-4119.
59. Guha M., Fang J.-K., Monks R., Birnbaum M.J., Avadhani N.G. Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol. Biol. Cell 2010, 21:3578-3589.
60. Halestrap A.P. What is the mitochondrial permeability transition pore?. J. Mol. Cell. Cardiol. 2009, 46:821-831.
61. Han S., Ritzenthaler J.D., Sun X., Zheng Y., Roman J. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha. Am. J. Respir. Cell Mol. Biol. 2009, 40:325-331.
62. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
63. Handschin C. The biology of PGC-1[alpha] and its therapeutic potential. Trends Pharmacol. Sci. 2009, 30:322-329.
64. Handschin C., Lin J., Rhee J., Peyer A.K., Chin S., Wu P.H., Meyer U.A., Spiegelman B.M. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 2005, 122:505-515.
65. Hock M.B., Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 2009, 71:177-203.
66. Holt I.J. Zen and the art of mitochondrial DNA maintenance. Trends Genet. 2010, 26:103-109.
67. Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719.
68. Horibata Y., Sugimoto H. StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria. J. Biol. Chem. 2010, 285:7358-7365.
69. Horibe T., Hoogenraad N.J. The Chop gene contains an element for the positive regulation of the mitochondrial unfolded protein response. PLoS One 2007, 2:e835.
70. Huss J.M., Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ. Res. 2004, 95:568-578.
71. Irrcher I., Ljubicic V., Hood D.A. Interactions between ROS and AMP kinase activity in the regulation of PGC-1α transcription in skeletal muscle cells. Am. J. Physiol. Cell Physiol. 2009, 296:C116-C123.
72. Ishikawa K., Koshikawa N., Takenaga K., Nakada K., Hayashi J.-I. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion 2008, 8:339-344.
73. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., Nakada K., Honma Y., Hayashi J.I. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008, 320:661-664.
74. Jeninga E.H., Schoonjans K., Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 2010, 29:4617-4624.
75. Jiang W.G., Douglas-Jones A., Mansel R.E. Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int. J. Cancer 2003, 106:752-757.
76. Jones D.P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 2008, 295:849-868.
77. Joseph A.M., Rungi A.A., Robinson B.H., Hood D.A. Compensatory responses of protein import and transcription factor expression in mitochondrial DNA defects. Am. J. Physiol. Cell Physiol. 2004, 286:C867-C875.
78. Kaipparettu B.A., Ma Y., Wong L.J. Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann. N. Y. Acad. Sci. 2010, 1201:137-146.
79. Kajimura S., Seale P., Tomaru T., Erdjument-Bromage H., Cooper M.P., Ruas J.L., Chin S., Tempst P., Lazar M.A., Spiegelman B.M. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev. 2008, 22:1397-1409.
80. Kajimura S., Seale P., Spiegelman B.M. Transcriptional control of brown fat development. Cell Metab. 2010, 11:257-262.
81. Kelly D.P., Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004, 18:357-368.
82. Klinge C.M. Estrogenic control of mitochondrial function and biogenesis. J. Cell. Biochem. 2008, 105:1342-1351.
83. Kong X., Fan H., Liu X., Wang R., Liang J., Gupta N., Chen Y., Fang F., Chang Y. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha enhances antiproliferative activity of 5J-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase. Mol. Pharmacol. 2009, 76:854-860.
84. Kressler D., Schreiber S.N., Knutti D., Kralli A. The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J. Biol. Chem. 2002, 277:13918-13925.
85. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., Hengartner M., Knight R.A., Kumar S., Lipton S.A., Malorni W., Nunez G., Peter M.E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16:3-11.
86. Kulawiec M., Safina A.F., Desouki M.M., Still I., Matsui S.-I., Bakin A., Singh K.K. Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol. Ther. 2008, 7:1732-1743.
87. Kulawiec M., Owens K.M., Singh K.K. Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol. Ther. 2009, 8:1378-1385.
88. Kulawiec M., Salk J.J., Ericson N.G., Wanagat J., Bielas J.H. Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer. Environ. Mol. Mutagen. 2010, 51:427-439.
89. Lai L., Leone T.C., Zechner C., Schaeffer P.J., Kelly S.M., Flanagan D.P., Medeiros D.M., Kovacs A., Kelly D.P. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 2008, 22:1948-1961.
90. Le Pennec S., Mirebeau-Prunier D., Boutet-Bouzamondo N., Jacques C., Guillotin D., Lauret E., Houlgatte R.M., Malthièry Y., Savagner F. Nitric oxide and calcium participate in the fine regulation of mitochondrial biogenesis in follicular thyroid carcinoma cells. J. Biol. Chem. 2011, 286:18229-18239.
91. Lee C.-H., Wu S.-B., Hong C.-H., Liao W.-T., Wu C.-Y., Chen G.-S., Wei Y.-H., Yu H.-S. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am. J. Pathol. 2011, 178:2066-2076.
92. Lelliott C.J., Medina-Gomez G., Petrovic N., Kis A., Feldmann H.M., Bjursell M., Parker N., Curtis K., Campbell M., Hu P., Zhang D., Litwin S.E., Zaha V.G., Fountain K.T., Boudina S., Jimenez-Linan M., Blount M., Lopez M., Meirhaeghe A., Bohlooly-Y M., Storlien L., Strömstedt M., Snaith M., Oresic M., Abel E.D., Cannon B., Vidal-Puig A. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 2006, 4:e369.
93. Lenka N., Basu A., Mullick J., Avadhani N.G. The role of an E box binding basic helix loop helix protein in the cardiac muscle-specific expression of the rat cytochrome oxidase subunit VIII gene. J. Biol. Chem. 1996, 271:30281-30289.
94. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., Courtois M., Wozniak D.F., Sambandam N., Bernal-Mizrachi C., Chen Z., Holloszy J.O., Medeiros D.M., Schmidt R.E., Saffitz J.E., Abel E.D., Semenkovich C.F., Kelly D.P. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005, 3:e101.
95. Liao X.S., Small W.C., Srere P.A., Butow R.A. Intramitochondrial functions regulate nonmitochondrial citrate synthase (CIT2) expression in Saccharomyces cerevisiae. Mol. Cell. Biol. 1991, 11:38-46.
96. Liao X., Wang Y., Wong C.W. Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor gamma co-activator-1alpha protein. Br. J. Pharmacol. 2010, 161:771-781.
97. Lin J.D. Minireview: the PGC-1 coactivator networks: chromatin-remodeling and mitochondrial energy metabolism. Mol. Endocrinol. 2009, 23:2-10.
98. Lin J., Puigserver P., Donovan J., Tarr P., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 2002, 277:1645-1648.
99. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 2002, 11:133-145.
100. Lin J., Wu P.-H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.-Y., Mootha V.K., Jäger S., Vianna C.R., Reznick R.M., Cui L., Manieri M., Donovan M.X., Wu Z., Cooper M.P., Fan M.C., Rohas L.M., Zavacki A.M., Cinti S., Shulman G.I., Lowell B.B., Krainc D., Spiegelman B.M. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119:121-135.
101. Lin J., Handschin C., Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005, 1:361-370.
102. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., Yang W., Pei L., Uldry M., Tontonoz P., Newgard C.B., Spiegelman B.M. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005, 120:261-273.
103. Ling C., Poulsen P., Carlsson E., Ridderstrale M., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 2004, 114:1518-1526.
104. Liu Z., Butow R.A. Mitochondrial retrograde signaling. Annu. Rev. Genet. 2006, 40:159-185.
105. Liu Z., Sekito T., Epstein C.B., Butow R.A. RTG-dependent mitochondria to nucleus signaling is negatively regulated by the seven WD-repeat protein Lst8p. EMBO J. 2001, 20:7209-7219.
106. Lombes A., Mendell J.R., Nakase H., Barohn R.J., Bonilla E., Zeviani M., Yates A.J., Omerza J., Gales T.L., Nakahara K., et al. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann. Neurol. 1989, 26:20-33.
107. Luce K., Weil A.C., Osiewacz H.D. Mitochondrial protein quality control systems in aging and disease. Adv. Exp. Med. Biol. 2010, 694:108-125.
108. Luo Y., Ingram V.M. Uncoupling of mitochondria activates protein phosphatases and inactivates MBP protein kinases. J. Alzheimers Dis. 2001, 3:593-598.
109. Luo Y., Bond J.D., Ingram V.M. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP,Äâkinases. Proc. Natl. Acad. Sci. 1997, 94:9705-9710.
110. Luo Y., Zhu W., Jia J., Zhang C., Xu Y. NMDA receptor dependent PGC-1alpha up-regulation protects the cortical neuron against oxygen-glucose deprivation/reperfusion injury. J. Molecular Neurosci. MN 2009, 39:262-268.
111. Lynn E.G., Stevens M.V., Wong R.P., Carabenciov D., Jacobson J., Murphy E., Sack M.N. Transient upregulation of PGC-1alpha diminishes cardiac ischemia tolerance via upregulation of ANT1. J. Mol. Cell. Cardiol. 2010, 49:693-698.
112. Magasanik B., Kaiser C.A. Nitrogen regulation in Saccharomyces cerevisiae. Gene 2002, 290:1-18.
113. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
114. Mandal S., Lindgren A.G., Srivastava A.S., Clark A.T., Banerjee U. Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells 2011, 29:486-495.
115. Marin-Garcia J. Thyroid hormone and myocardial mitochondrial biogenesis. Vascul. Pharmacol. 2010, 52:120-130.
116. Martin E., Betuing S., Pagès C., Cambon K., Auregan G., Deglon N., Roze E., Caboche J. Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum. Mol. Genet. 2011, 20:2422-2434.
117. Martinus R.D., Garth G.P., Webster T.L., Cartwright P., Naylor D.J., Hoj P.B., Hoogenraad N.J. Selective induction of mitochondrial chaperones in response to loss of the mitochondrial genome. FEBS J. 1996, 240:98-103.
118. Marusich M.F., Robinson B.H., Taanman J.-W., Kim S.J., Schillace R., Smith J.L., Capaldi R.A. Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1997, 1362:145-159.
119. Maruszak A., Safranow K., Branicki W., Gawôôda-Walerych K., Pospiech E., Gabryelewicz T., Canter J.A., Barcikowska M., Zekanowski C. The impact of mitochondrial and nuclear DNA variants on Late-onset Alzheimer's disease risk. J. Alzheimers Dis. 2011, 25:1-14.
120. McCammon M.T., Epstein C.B., Przybyla-Zawislak B., McAlister-Henn L., Butow R.A. Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes. Mol. Biol. Cell 2003, 14:958-972.
121. Menzies K.J., Robinson B.H., Hood D.A. Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects. Am. J. Physiol. Cell Physiol. 2009, 296:C355-C362.
122. Mercy L., Pauw A., Payen L., Tejerina S., Houbion A., Demazy C., Raes M., Renard P., Arnould T. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2+-dependent pathway and a reduced mitochondrial protein import. FEBS J. 2005, 272:5031-5055.
123. Miglio G., Rosa A.C., Rattazzi L., Collino M., Lombardi G., Fantozzi R. PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss. Neurochem. Int. 2009, 55:496-504.
124. Miranda S., Foncea R., Guerrero J., Leighton F. Oxidative stress and upregulation of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells. Biochem. Biophys. Res. Commun. 1999, 258:44-49.
125. Mirebeau-Prunier D., Le Pennec S., Jacques C., Gueguen N., Poirier J., Malthiery Y., Savagner F. Estrogen-related receptor alpha and PGC-1-related coactivator constitute a novel complex mediating the biogenesis of functional mitochondria. FEBS J. 2010, 277:713-725.
126. Miwa S., Lawless C., von Zglinicki T. Mitochondrial turnover in liver is fast in vivo and is accelerated by dietary restriction: application of a simple dynamic model. Aging Cell 2008, 7:920-923.
127. Moisoi N., Klupsch K., Fedele V., East P., Sharma S., Renton A., Plun-Favreau H., Edwards R.E., Teismann P., Esposti M.D., Morrison A.D., Wood N.W., Downward J., Martins L.M. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ. 2009, 16:449-464.
128. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
129. Moraes C.T., DiMauro S., Zeviani M., Lombes A., Shanske S., Miranda A.F., Nakase H., Bonilla E., Werneck L.C., Servidei S., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N. Engl. J. Med. 1989, 320:1293-1299.
130. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., Movilla N., Perez-Martos A., de Cordoba S.R., Gallardo M.E., Enriquez J.A. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat. Genet. 2006, 38:1261-1268.
131. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
132. Nemoto S., Fergusson M.M., Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J. Biol. Chem. 2005, 280:16456-16460.
133. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., Bracale R., Valerio A., Francolini M., Moncada S., Carruba M.O. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
134. O'Malley B.W., Kumar R. Nuclear receptor coregulators in cancer biology. Cancer Res. 2009, 69:8217-8222.
135. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 2003, 4:552-565.
136. Owusu-Ansah E., Yavari A., Mandal S., Banerjee U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat. Genet. 2008, 40:356-361.
137. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., Walford G.A., Sugiana C., Boneh A., Chen W.K., Hill D.E., Vidal M., Evans J.G., Thorburn D.R., Carr S.A., Mootha V.K. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
138. Parikh V.S., Morgan M.M., Scott R., Clements L.S., Butow R.A. The mitochondrial genotype can influence nuclear gene expression in yeast. Science 1987, 235:576-580.
139. Piantadosi C.A., Suliman H.B. Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1. J. Biol. Chem. 2006, 281:324-333.
140. Potting C., Wilmes C., Engmann T., Osman C., Langer T. Regulation of mitochondrial phospholipids by Ups1/PRELI-like proteins depends on proteolysis and Mdm35. EMBO J. 2010, 29:2888-2898.
141. Pray-Grant M.G., Schieltz D., McMahon S.J., Wood J.M., Kennedy E.L., Cook R.G., Workman J.L., Yates Iii J.R., Grant P.A. The novel SLIK histone acetyltransferase complex functions in the yeast retrograde response pathway. Mol. Cell. Biol. 2002, 22:8774-8786.
142. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
143. Qin W., Haroutunian V., Katsel P., Cardozo C.P., Ho L., Buxbaum J.D., Pasinetti G.M. PGC-1{alpha} expression decreases in the Alzheimer disease brain as a function of dementia. Arch. Neurol. 2009, 66:352-361.
144. Qin W., Pan J., Wu Y., Bauman W.A., Cardozo C. Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1[alpha]. Biochem. Biophys. Res. Commun. 2010, 403:473-478.
145. Ranganathan S., Harmison G.G., Meyertholen K., Pennuto M., Burnett B.G., Fischbeck K.H. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009, 18:27-42.
146. Rasbach K.A., Gupta R.K., Ruas J.L., Wu J., Naseri E., Estall J.L., Spiegelman B.M. PGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types. PNAS 2010, 107:21866-21871.
147. Reeve A.K., Krishnan K.J., Turnbull D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:21-29.
148. Rhodes M.A., Carraway M.S., Piantadosi C.A., Reynolds C.M., Cherry A.D., Wester T.E., Natoli M.J., Massey E.W., Moon R.E., Suliman H.B. Carbon monoxide, skeletal muscle oxidative stress, and mitochondrial biogenesis in humans. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H392-H399.
149. Roberts A.M., Watson I.R., Evans A.J., Foster D.A., Irwin M.S., Ohh M. Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res. 2009, 69:9056-9064.
150. Rohas L.M., St-Pierre J., Uldry M., Jager S., Handschin C., Spiegelman B.M. A fundamental system of cellular energy homeostasis regulated by PGC-1alpha. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7933-7938.
151. Russell L.K., Mansfield C.M., Lehman J.J., Kovacs A., Courtois M., Saffitz J.E., Medeiros D.M., Valencik M.L., McDonald J.A., Kelly D.P. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor Œ-coactivator-1Œ± promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res. 2004, 94:525-533.
152. Sano M., Wang S.C., Shirai M., Scaglia F., Xie M., Sakai S., Tanaka T., Kulkarni P.A., Barger P.M., Youker K.A., Taffet G.E., Hamamori Y., Michael L.H., Craigen W.J., Schneider M.D. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J. 2004, 23:3559-3569.
153. Savagner F., Mirebeau D., Jacques C., Guyetant S., Morgan C., Franc B., Reynier P., Malthièry Y. PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. Biochem. Biophys. Res. Commun. 2003, 310:779-784.
154. Scarpulla R.C. Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 2006, 97:673-683.
155. Scarpulla R.C. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann. N. Y. Acad. Sci. 2008, 1147:321-334.
156. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88:611-638.
157. Scarpulla R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network Biochim. Biophys. Acta 2011, 1813(7):1269-1278.
158. Schmidt O., Pfanner N., Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat. Rev. Mol. Cell Biol. 2010, 11:655-667.
159. Shin J.-H., Ko H.S., Kang H., Lee Y., Lee Y.-I., Pletinkova O., Troconso J.C., Dawson V.L., Dawson T.M. PARIS (ZNF746) repression of PGC-1[alpha] contributes to neurodegeneration in Parkinson's disease. Cell 2011, 144:689-702.
160. Shiota M., Yokomizo A., Tada Y., Inokuchi J., Tatsugami K., Kuroiwa K., Uchiumi T., Fujimoto N., Seki N., Naito S. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol. Endocrinol. (Baltimore, Md.) 2010, 24:114-127.
161. Shoubridge E.A., Karpati G., Hastings K.E. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 1990, 62:43-49.
162. Shutt T.E., Shadel G.S. A compendium of human mitochondrial gene expression machinery with links to disease. Environ. Mol. Mutagen. 2010, 51:360-379.
163. Sickmann A., Reinders J., Wagner Y., Joppich C., Zahedi R., Meyer H.E., Schonfisch B., Perschil I., Chacinska A., Guiard B., Rehling P., Pfanner N., Meisinger C. The proteome of Saccharomyces cerevisiae mitochondria. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13207-13212.
164. Siegelin M.D., Dohi T., Raskett C.M., Orlowski G.M., Powers C.M., Gilbert C.A., Ross A.H., Plescia J., Altieri D.C. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J. Clin. Invest. 2011, 121:1349-1360.
165. Simon D.K., Lin M.T., Zheng L., Liu G.J., Ahn C.H., Kim L.M., Mauck W.M., Twu F., Beal M.F., Johns D.R. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 2004, 25:71-81.
166. Smigrodzki R., Parks J., Parker W.D. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol. Aging 2004, 25:1273-1281.
167. Spiegelman B.M., Puigserver P., Wu Z. Regulation of adipogenesis and energy balance by PPARgamma and PGC-1. Int. J. Obes. Relat. Metab. Disord. 2000, 24(Suppl 4):S8-S10.
168. Srinivasan V., Kriete A., Sacan A., Michal Jazwinski S. Comparing the yeast retrograde response and NF-κB stress responses: implications for aging. Aging Cell 2010, 9:933-941.
169. Srivastava S., Barrett J.N., Moraes C.T. PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Hum. Mol. Genet. 2007, 16:993-1005.
170. St-Pierre J., Lin J., Krauss S., Tarr P.T., Yang R., Newgard C.B., Spiegelman B.M. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J. Biol. Chem. 2003, 278:26597-26603.
171. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jäger S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
172. Suzuki H., Kumagai T., Goto A., Sugiura T. Increase in intracellular hydrogen peroxide and upregulation of a nuclear respiratory gene evoked by impairment of mitochondrial electron transfer in human cells. Biochem. Biophys. Res. Commun. 1998, 249:542-545.
173. Swerdlow R.H. The neurodegenerative mitochondriopathies. J. Alzheimers Dis. 2009, 17:737-751.
174. Taherzadeh-Fard E., Saft C., Akkad D., Wieczorek S., Haghikia A., Chan A., Epplen J., Arning L. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol. Neurodegener. 2011, 6:32.
175. Tamura Y., Endo T., Iijima M., Sesaki H. Ups1p and Ups2p antagonistically regulate cardiolipin metabolism in mitochondria. J. Cell Biol. 2009, 185:1029-1045.
176. Tatsuta T., Langer T. Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J. 2008, 27:306-314.
177. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6:389-402.
178. Traven A., Wong J.M.S., Xu D., Sopta M., Ingles C.J. Interorganellar communication. J. Biol. Chem. 2001, 276:4020-4027.
179. Tuppen H.A., Blakely E.L., Turnbull D.M., Taylor R.W. Mitochondrial DNA mutations and human disease. Biochim. Biophys. Acta 2010, 1797:113-128.
180. Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 2008, 1777:1092-1097.
181. Valle I., Alvarez-Barrientos A., Arza E., Lamas S., Monsalve M. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc. Res. 2005, 66:562-573.
182. Vance J.E., Vance D.E. Phospholipid biosynthesis in mammalian cells. Biochem. Cell Biol. 2004, 82:113-128.
183. Vercauteren K., Pasko R.A., Gleyzer N., Marino V.M., Scarpulla R.C. PGC-1-related coactivator: immediate early expression and characterization of a CREB/NRF-1 binding domain associated with cytochrome c promoter occupancy and respiratory growth. Mol. Cell. Biol. 2006, 26:7409-7419.
184. Vercauteren K., Gleyzer N., Scarpulla R.C. Short hairpin RNA-mediated silencing of PRC (PGC-1-related coactivator) results in a severe respiratory chain deficiency associated with the proliferation of aberrant mitochondria. J. Biol. Chem. 2009, 284:2307-2319.
185. Verger A., Quinlan K.G.R., Crofts L.A., Spano S., Corda D., Kable E.P.W., Braet F., Crossley M. Mechanisms directing the nuclear localization of the CtBP family proteins. Mol. Cell. Biol. 2006, 26:4882-4894.
186. Wada T., Gao J., Xie W. PXR and CAR in energy metabolism. Trends Endocrinol. Metab. 2009, 20:273-279.
187. Wallace D.C. Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu. Rev. Biochem. 2007, 76:781-821.
188. Wallace D.C. Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 2010, 51:440-450.
189. Wan B., Moreadith R.W. Structural characterization and regulatory element analysis of the heart isoform of cytochrome c oxidase VIa. J. Biol. Chem. 1995, 270:26433-26440.
190. Wang, X., Moraes, C.T., 2011. Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels. Mol. Oncol. 5 (5), 399-409.
191. Wang H., Morais R. Up-regulation of nuclear genes in response to inhibition of mitochondrial DNA expression in chicken cells. Biochim. Biophys. Acta (BBA) - Gene Struct. Expression 1997, 1352:325-334.
192. Watkins G., Douglas-Jones A., Mansel R.E., Jiang W.G. The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer. Oncol. Rep. 2004, 12:483-488.
193. Wenz T. PGC-1α activation as a therapeutic approach in mitochondrial disease. IUBMB Life 2009, 61:1051-1062.
194. Wenz T. Mitochondria and PGC-1α in aging and age-associated diseases. J. Aging Res Volume 2011, 2011. 10.4061/2011/810619 (epub.
195. Wenz T., Wang X., Marini M., Moraes C.T. A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations. J Cell Mol Med. 2010.
196. Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., Cui L., Beyer R.P., Easley C.N., Smith A.C., Krainc D., Luquet S., Sweet I.R., Schwartz M.W., La Spada A.R. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 2006, 4:349-362.
197. Weydt P., Soyal S., Gellera C., DiDonato S., Weidinger C., Oberkofler H., Landwehrmeyer G.B., Patsch W. The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. Mol. Neurodegener. 2009, 4:3.
198. Williamson D.H., Lund P., Krebs H.A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 1967, 103:514-527.
199. Wojewoda M., Duszynski J., Szczepanowska J. NARP mutation and mtDNA depletion trigger mitochondrial biogenesis which can be modulated by selenite supplementation. Int. J. Biochem. Cell Biol. 2011, 43:1178-1186.
200. Won J.C., Park J.-Y., Kim Y.M., Koh E.H., Seol S., Jeon B.H., Han J., Kim J.R., Park T.-S., Choi C.S., Lee W.J., Kim M.-S., Lee I.-K., Youn J.H., Lee K.-U. Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha overexpression prevents endothelial apoptosis by increasing ATP/ADP translocase activity. Arterioscler. Thromb. Vasc. Biol. 2010, 30:290-297.
201. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
202. Xiang Z., Valenza M., Cui L., Leoni V., Jeong H.-K., Brilli E., Zhang J., Peng Q., Duan W., Reeves S.A., Cattaneo E., Krainc D. Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease. J. Neurosci. 2011, 31:9544-9553.
203. Xiong S., Salazar G., San Martin A., Ahmad M., Patrushev N., Hilenski L., Nazarewicz R.R., Ma M., Ushio-Fukai M., Alexander R.W. PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. J. Biol. Chem. 2010, 285:2474-2487.
204. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
205. Zechner C., Lai L., Zechner J.F., Geng T., Yan Z., Rumsey J.W., Collia D., Chen Z., Wozniak D.F., Leone T.C., Kelly D.P. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab. 2010, 12:633-642.
206. Zhang X., Moye-Rowley W.S. Saccharomyces cerevisiae multidrug resistance gene expression inversely correlates with the status of the F0 component of the mitochondrial ATPase. J. Biol. Chem. 2001, 276:47844-47852.
207. Zhang Y., Castellani L.W., Sinal C.J., Gonzalez F.J., Edwards P.A. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 2004, 18:157-169.
208. Zhang Q., Wang S.-Y., Fleuriel C., Leprince D., Rocheleau J.V., Piston D.W., Goodman R.H. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:829-833.
209. Zhang Y., Ba Y., Liu C., Sun G., Ding L., Gao S., Hao J., Yu Z., Zhang J., Zen K., Tong Z., Xiang Y., Zhang C.-Y. PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. Cell Res. 2007, 17:363-373.
210. Zhang Y., Huypens P., Adamson A.W., Chang J.S., Henagan T.M., Boudreau A., Lenard N.R., Burk D., Klein J., Perwitz N., Shin J., Fasshauer M., Kralli A., Gettys T.W. Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J. Biol. Chem. 2009, 284:32813-32826.
211. Zhao W., Varghese M., Yemul S., Pan Y., Cheng A., Marano P., Hassan S., Vempati P., Chen F., Qian X., Pasinetti G. Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener. 2011, 6:51.
212. Zheng B., Liao Z., Locascio J.J., Lesniak K.A., Roderick S.S., Watt M.L., Eklund A.C., Zhang-James Y., Kim P.D., Hauser M.A., Grünblatt E., Moran L.B., Mandel S.A., Riederer P., Miller R.M., Federoff H.J., Wüllner U., Papapetropoulos S., Youdim M.B., Cantuti-Castelvetri I., Young A.B., Vance J.M., Davis R.L., Hedreen J.C., Adler C.H., Beach T.G., Graeber M.B., Middleton F.A., Rochet J.C., Scherzer C.R. Global PD Gene Expression (GPEX) Consortium PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med. 2010, 2(52):52ra73.
213. Zorzano A., Hernández-Alvarez M.I., Palacín M., Mingrone G. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim. Biophys. Acta 2010, 1797(6-7):1028-1033.